Literature DB >> 28676924

The P2X7 Receptor.

Ronald Sluyter1,2,3.   

Abstract

The P2X7 receptor is a trimeric ion channel gated by extracellular adenosine 5'-triphosphate. The receptor is present on an increasing number of different cells types including stem, blood, glial, neural, ocular, bone, dental, exocrine, endothelial, muscle, renal and skin cells. The P2X7 receptor induces various downstream events in a cell-specific manner, including inflammatory molecule release, cell proliferation and death, metabolic events, and phagocytosis. As such this receptor plays important roles in heath and disease. Increasing knowledge about the P2X7 receptor has been gained from studies of, but not limited to, protein chemistry including cloning, site-directed mutagenesis, crystal structures and atomic modeling, as well as from studies of primary tissues and transgenic mice. This chapter focuses on the P2X7 receptor itself. This includes the P2RX7 gene and its products including splice and polymorphic variants. This chapter also reviews modulators of P2X7 receptor activation and inhibition, as well as the transcriptional regulation of the P2RX7 gene via its promoter and enhancer regions, and by microRNA and long-coding RNA. Furthermore, this chapter discusses the post-translational modification of the P2X7 receptor by N-linked glycosylation, adenosine 5'-diphosphate ribosylation and palmitoylation. Finally, this chapter reviews interaction partners of the P2X7 receptor, and its cellular localisation and trafficking within cells.

Entities:  

Keywords:  Extracellular ATP; Gene transcription; Interaction partner; Ionotropic receptor; Ligand-gated ion channel; P2RX7 gene; P2X7 interactome; P2X7 receptor; Post-translational modification; Purinergic receptor; Purinergic signaling; Receptor localisation; Receptor trafficking; Single nucleotide polymorphism; Splice variant

Mesh:

Substances:

Year:  2017        PMID: 28676924     DOI: 10.1007/5584_2017_59

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  50 in total

1.  Association of P2RX7 functional variants with localized aggressive periodontitis.

Authors:  Theodore H Harris; Margaret R Wallace; Hong Huang; Hua Li; Azeem Mohiuddeen; Yan Gong; Theodora Kompotiati; Peter Harrison; Ikramuddin Aukhil; Luciana M Shaddox
Journal:  J Periodontal Res       Date:  2019-07-10       Impact factor: 4.419

2.  Role of TRPV4-P2X7 Pathway in Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion.

Authors:  Xiaohua Fan; Chuanwei Wang; Junting Han; Xinli Ding; Shaocan Tang; Liping Ning
Journal:  Neurochem Res       Date:  2021-05-20       Impact factor: 3.996

3.  Involvement of P2X7 Receptors in the Osteogenic Differentiation of Mesenchymal Stromal/Stem Cells Derived from Human Subcutaneous Adipose Tissue.

Authors:  Marzia Carluccio; Mariachiara Zuccarini; Sihana Ziberi; Patricia Giuliani; Caterina Morabito; Maria A Mariggiò; Maria Teresa Lonardo; Elena Adinolfi; Elisa Orioli; Patrizia Di Iorio; Francesco Caciagli; Renata Ciccarelli
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

4.  Associations of P2RX7 Functional Diplotypes with Localized Aggressive Periodontitis.

Authors:  T H Harris; M R Wallace; H Huang; H Li; L M Shaddox
Journal:  JDR Clin Trans Res       Date:  2019-07-18

5.  Ca2+ flux through splice variants of the ATP-gated ionotropic receptor P2X7 is regulated by its cytoplasmic N terminus.

Authors:  Xin Liang; Damien S K Samways; Jane Cox; Terrance M Egan
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

6.  The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice.

Authors:  Diane Ly; Anjila Dongol; Peter Cuthbertson; Thomas V Guy; Nicholas J Geraghty; Reece A Sophocleous; Lucia Sin; Bradley J Turner; Debbie Watson; Justin J Yerbury; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2020-03-13       Impact factor: 3.765

Review 7.  Purinergic signaling and tumor microenvironment in cervical Cancer.

Authors:  Marta Schmidt Pfaffenzeller; Maria Luiza Mukai Franciosi; Andréia Machado Cardoso
Journal:  Purinergic Signal       Date:  2020-03-13       Impact factor: 3.765

Review 8.  Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington's and Parkinson's Disease.

Authors:  Talita Glaser; Roberta Andrejew; Ágatha Oliveira-Giacomelli; Deidiane Elisa Ribeiro; Lucas Bonfim Marques; Qing Ye; Wen-Jing Ren; Alexey Semyanov; Peter Illes; Yong Tang; Henning Ulrich
Journal:  Neurosci Bull       Date:  2020-10-07       Impact factor: 5.203

Review 9.  P2X7 receptor: a critical regulator and potential target for breast cancer.

Authors:  Xiaodi Zhu; Qianqian Li; Wei Song; Xiaoxiang Peng; Ronglan Zhao
Journal:  J Mol Med (Berl)       Date:  2021-01-23       Impact factor: 4.599

10.  EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.

Authors:  Chien-Feng Li; Ti-Chun Chan; Cheng-Tang Pan; Pichpisith Pierre Vejvisithsakul; Jia-Chen Lai; Szu-Yu Chen; Ya-Wen Hsu; Meng-Shin Shiao; Yow-Ling Shiue
Journal:  Cell Oncol (Dordr)       Date:  2021-08-02       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.